JAK2 and neoplasm: Subsequent work reported that activation of Janus kinase-2/signal transducer and activator of transcription-3 (Jak2/Stat3) pathway in PTEN-null senescent prostate tumors established an immunosuppressive tumor microenvironment thereby leading to its growth and chemoresistance.